Sailing Capital Overseas Investments Fund, LP 3
3 · Cellular Biomedicine Group, Inc. · Filed Feb 28, 2020
Insider Transaction Report
Form 3
Holdings
- 1,712,920(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.